Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-15

FDA Approved: PATADAY ONCE DAILY RELIEF — Supplemental Application (Alcon Laboratories, Inc.)

View source ↗

Summary

FDA approved a supplemental application for PATADAY ONCE DAILY RELIEF (olopatadine hydrochloride) from Alcon Laboratories, expanding the labeling to include a o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PATADAY ONCE DAILY RELIEF (OLOPATADINE HYDROCHLORIDE)

Snippet

SUPPL AP for PATADAY ONCE DAILY RELIEF (OLOPATADINE HYDROCHLORIDE)